Product Surveillance, Postmarketing
"Product Surveillance, Postmarketing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Surveillance of drugs, devices, appliances, etc., for efficacy or adverse effects, after they have been released for general sale.
| Descriptor ID |
D011358
|
| MeSH Number(s) |
E05.337.800
|
| Concept/Terms |
Product Surveillance, Postmarketing- Product Surveillance, Postmarketing
- Product Surveillance, Post-Marketing
- Post-Marketing Product Surveillance
- Post-Marketing Product Surveillances
- Product Surveillance, Post Marketing
- Product Surveillances, Post-Marketing
- Surveillance, Post-Marketing Product
- Surveillances, Post-Marketing Product
- Evaluation Studies, Postmarketing
- Evaluation Study, Postmarketing
- Postmarketing Evaluation Studies
- Postmarketing Evaluation Study
- Studies, Postmarketing Evaluation
- Study, Postmarketing Evaluation
- Postmarketing Product Surveillance
- Postmarketing Product Surveillances
- Product Surveillances, Postmarketing
- Surveillance, Postmarketing Product
- Surveillances, Postmarketing Product
Drug Surveillance, Postmarketing- Drug Surveillance, Postmarketing
- Drug Surveillances, Postmarketing
- Postmarketing Drug Surveillance
- Postmarketing Drug Surveillances
- Surveillance, Postmarketing Drug
- Surveillances, Postmarketing Drug
|
Below are MeSH descriptors whose meaning is more general than "Product Surveillance, Postmarketing".
Below are MeSH descriptors whose meaning is more specific than "Product Surveillance, Postmarketing".
This graph shows the total number of publications written about "Product Surveillance, Postmarketing" by people in this website by year, and whether "Product Surveillance, Postmarketing" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 1 | 2 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 1 | 2 |
| 2017 | 13 | 10 | 23 |
| 2018 | 7 | 12 | 19 |
| 2019 | 8 | 5 | 13 |
| 2020 | 2 | 1 | 3 |
| 2021 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Product Surveillance, Postmarketing" by people in Profiles.
-
DrugWAS: Drug-wide Association Studies for COVID-19 Drug Repurposing. Clin Pharmacol Ther. 2021 12; 110(6):1537-1546.
-
Informing selection of drugs for COVID-19 treatment through adverse events analysis. Sci Rep. 2021 07 07; 11(1):14022.
-
Global covid-19 vaccine rollout and safety surveillance-how to keep pace. BMJ. 2021 06 18; 373:n1416.
-
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021. MMWR Morb Mortal Wkly Rep. 2021 May 07; 70(18):680-684.
-
A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel System. Pharmacoepidemiol Drug Saf. 2021 07; 30(7):827-837.
-
Suitability of databases in the Asia-Pacific for collaborative monitoring of vaccine safety. Pharmacoepidemiol Drug Saf. 2021 07; 30(7):843-857.
-
Estimating Baseline Incidence of Conditions Potentially Associated with Vaccine Adverse Events: a Call for Surveillance System Using the Korean National Health Insurance Claims Data. J Korean Med Sci. 2021 Mar 08; 36(9):e67.
-
The Need for Novel Approaches in Assessing the Value of COVID-19 Vaccines. Am J Public Health. 2021 02; 111(2):205-208.
-
General determination of causation between Covid-19 vaccines and possible adverse events. Vaccine. 2021 03 05; 39(10):1478-1480.
-
Vaccine Development: From Laboratory to Policy. Pediatr Ann. 2020 Dec 01; 49(12):e509-e515.